KRTX

Karuna Therapeutics, Inc. Common Stock
KRTX

Overview Fund Activity
Delisted

KRTX was delisted on the 15th of March, 2024.

Back to rankings

171 hedge funds and large institutions have $3.83B invested in Karuna Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 58 increasing their positions, 52 reducing their positions, and 15 closing their positions.

Holders
171
Holders Change
+12
Holders Change %
+7.55%
% of All Funds
2.64%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.12%
New
28
Increased
58
Reduced
52
Closed
15
Calls
$8.28M
Puts
$6.7M
Net Calls
+$1.58M
Net Calls Change
-$1.31M

Top Buyers

1
Victory Capital Management
1
Victory Capital Management
Texas
$37M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$15.5M
3
EMFAT
3
Emerald Mutual Fund Advisers Trust
Pennsylvania
$30.1M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$256M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$12.2M

Top Sellers

1
LGM
1
Logos Global Management
California
$39.3M
2
FCM
2
Farallon Capital Management
California
$72.1M
3
PAMS
3
Pictet Asset Management (Switzerland)
Switzerland
$25.7M
4
Lord, Abbett & Co
4
Lord, Abbett & Co
New Jersey
$31.7M
5
First Trust Advisors
5
First Trust Advisors
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
EA
26
Emerald Advisers
Pennsylvania
$30.2M +$2.47M +18,850 +9%
EMFAT
27
Emerald Mutual Fund Advisers Trust
Pennsylvania
$30.1M +$15.4M +117,851 +106%
Northern Trust
28
Northern Trust
Illinois
$28.2M -$421K -3,217 -1%
Franklin Resources
29
Franklin Resources
California
$28M +$629K +4,800 +2%
Norges Bank
30
Norges Bank
Norway
$27.9M +$3.83M +29,222 +16%
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$26.4M +$2.59M +19,801 +11%
PAMS
32
Pictet Asset Management (Switzerland)
Switzerland
$25.7M -$19.6M -149,541 -43%
Jennison Associates
33
Jennison Associates
New York
$23.6M +$12M +91,909 +104%
PHS
34
PFM Health Sciences
California
$23.2M – – –
Charles Schwab
35
Charles Schwab
California
$20.4M +$417K +3,186 +2%
Goldman Sachs
36
Goldman Sachs
New York
$19.8M -$83.2K -635 -0.4%
DTC
37
Deep Track Capital
Connecticut
$17.1M +$17.1M +130,200 New
American Century Companies
38
American Century Companies
Missouri
$17M +$282K +2,152 +2%
Adage Capital Partners
39
Adage Capital Partners
Massachusetts
$15.5M +$15.5M +118,594 New
HRCM
40
Hood River Capital Management
Florida
$15.2M -$9.56K -73 -0.1%
TCM
41
Tekla Capital Management
Massachusetts
$13.2M – – –
Impax Asset Management Group
42
Impax Asset Management Group
United Kingdom
$13M +$693K +5,289 +6%
Point72 Asset Management
43
Point72 Asset Management
Connecticut
$12.2M +$12.2M +93,097 New
Bank of New York Mellon
44
Bank of New York Mellon
New York
$11.9M +$200K +1,530 +2%
Morgan Stanley
45
Morgan Stanley
New York
$10.3M +$3.86M +29,480 +60%
Capital International Investors
46
Capital International Investors
California
$10.3M – – –
ACM
47
Atika Capital Management
New York
$9.83M +$9.83M +75,000 New
Axa
48
Axa
France
$9.76M +$116K +889 +1%
DCM
49
DAFNA Capital Management
California
$9.49M -$283K -2,162 -3%
Citigroup
50
Citigroup
New York
$9.42M +$6.5M +49,615 +223%
1
2
3 4 5